Recent Advances in Cancer Stem Cell-Targeted Immunotherapy

Recent Advances in Cancer Stem Cell-Targeted Immunotherapy

Cancer stem cells (CSCs) are one of the reasons for the relapse of cancer cells and metastasis. They have drug resistance against most chemotherapeutic agents. CSCs are also responsible for tumor cell heterogeneity and cause minimal residual disease. In order to achieve complete regression of tumors...

Full description

Bibliographic Details
Main Authors: Narayanasamy Badrinath, So Young Yoo
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Cancers
Subjects:
cancer stem cells
immunotherapy
combination therapy
Online Access:http://www.mdpi.com/2072-6694/11/3/310

Similar Items

Similar Items